Medicare Legal Rights and Appeals Process

Medicare enrollees hold a defined set of legal rights under federal statute and regulation, including the right to challenge coverage denials, claim terminations, and payment decisions through a structured administrative appeals process. This page covers the scope of those rights, the mechanics of the five-level appeals framework, the most common situations that trigger formal challenges, and the boundaries that determine which pathway applies. Understanding this process is material to protecting access to care under one of the largest federal health programs in the United States, which served approximately 65 million beneficiaries as of the Centers for Medicare & Medicaid Services (CMS) 2023 enrollment data (CMS Medicare Enrollment Dashboard).

Definition and scope

Medicare legal rights are the enforceable entitlements granted to enrollees under Title XVIII of the Social Security Act and implemented through regulations codified primarily at 42 C.F.R. Parts 405, 422, 423, and 478. These rights fall into two broad categories:

Substantive rights — the entitlement to covered benefits when eligibility criteria are met, including hospital care under Part A, physician and outpatient services under Part B, prescription drug coverage under Part D, and the coordinated benefits available through Medicare Advantage (Part C) plans.

Procedural rights — the entitlement to receive written notice of adverse decisions, to request reconsideration, and to pursue escalating levels of formal appeal up to and including federal court review.

The Medicare Rights Center, a federally recognized consumer assistance organization, characterizes these procedural protections as the primary mechanism through which statutory benefit entitlements are made practically enforceable. The appeals framework applies to Original Medicare (Parts A and B), Medicare Advantage plans, and Part D drug plans, though the specific administrative track differs by program type.

For context on how Medicare fits within the broader framework of elder law, see Elder Law Overview: US Legal Framework.

How it works

The appeals process for Original Medicare Parts A and B operates through five sequential levels, established under 42 C.F.R. § 405.900 et seq.:

1. Redetermination — Filed with the Medicare Administrative Contractor (MAC) that issued the initial denial. Deadline: 120 days from receipt of the initial decision. The MAC must issue a decision within 60 days.

2. Reconsideration — Filed with a Qualified Independent Contractor (QIC), an entity independent of the MAC. Deadline: 180 days from receipt of the redetermination. The QIC must decide within 60 days.

3. Administrative Law Judge (ALJ) Hearing — Available when the amount in controversy meets the threshold set annually by CMS. For 2024, that threshold is $180 (OMHA Amounts in Controversy). Conducted by the Office of Medicare Hearings and Appeals (OMHA) within the Department of Health and Human Services (HHS).

4. Medicare Appeals Council Review — Conducted by the Departmental Appeals Board (DAB) within HHS. Either party to the ALJ decision may escalate. Deadline: 60 days from receipt of the ALJ decision.

5. Federal District Court — Available when the amount in controversy reaches the judicially reviewed threshold, which for 2024 is $1,800 (OMHA Federal Court Thresholds). Claims are filed under 42 U.S.C. § 405(g).

Medicare Advantage (Part C) appeals follow a parallel but distinct track governed by 42 C.F.R. Part 422, Subpart M. Initial organization determinations are made by the plan; reconsideration is handled by an Independent Review Entity (IRE) contracted by CMS. Part D drug plan appeals follow 42 C.F.R. Part 423, Subpart M and mirror the Part C structure with plan-level coverage determinations subject to IRE review.

A critical procedural distinction: for inpatient hospital discharges, a beneficiary who requests a Expedited Determination through a Beneficiary and Family Centered Care Quality Improvement Organization (BFCC-QIO) before discharge is protected from financial liability for continued days while the appeal is pending, under 42 C.F.R. § 405.1200.

Common scenarios

Medicare appeals most frequently arise in five categories of adverse decision:

• Inpatient hospital discharge disputes — A hospital issues a Notice of Medicare Non-Coverage (NOMNC) stating inpatient care will end. The beneficiary may request a QIO review within the timeframe stated on the notice (typically by noon of the day before the planned discharge).

• Skilled nursing facility (SNF) coverage denials — Medicare covers SNF care only following a qualifying 3-day inpatient hospital stay (42 C.F.R. § 409.30). Denials based on alleged failure to meet the "improvement standard" have been addressed by the Jimmo v. Sebelius settlement (D. Vt. 2013), which clarified that maintenance care may qualify under Medicare even without expectation of improvement.

• Home health service terminations — Coverage disputes often center on whether the beneficiary meets the "homebound" definition under 42 C.F.R. § 409.42.

• Part D coverage and formulary disputes — Enrollees may request exceptions when a needed drug is not on a plan's formulary or is placed on a higher cost-sharing tier. Exception requests are governed by 42 C.F.R. § 423.578.

• Medicare Advantage organization determinations — Disputes over prior authorization denials for procedures, specialist referrals, or durable medical equipment (DME) represent a large share of Part C appeals activity.

These scenarios intersect with Nursing Home Residents' Legal Rights and are frequently relevant to Long-Term Care Planning Legal Considerations.

Decision boundaries

Several structural factors determine which appeal track applies and what relief is available:

Program type governs the track. Original Medicare (Parts A and B) appeals go through the MAC–QIC–ALJ–DAB–court sequence. Medicare Advantage and Part D appeals use the plan–IRE–ALJ–DAB–court sequence. A beneficiary cannot cross tracks; a Part C enrollee does not file with the MAC.

Amount in controversy thresholds gate access. ALJ hearings and federal court review require minimum dollar amounts, recalculated annually by CMS. Below the ALJ threshold ($180 for 2024), the DAB offers review without an in-person hearing, but federal court access is unavailable.

Timeliness is jurisdictional. Missing a filing deadline at any level — particularly the 120-day redetermination window or the 60-day escalation windows — can foreclose that avenue entirely. "Good cause" exceptions exist but are narrowly construed under 42 C.F.R. § 405.942.

Expedited versus standard timelines. For Medicare Advantage and Part D, enrollees may request expedited review when standard timelines would seriously jeopardize health. Plans must respond within 72 hours to expedited organization determination requests and within 24 hours to expedited grievances involving urgent care denials (42 C.F.R. § 422.572).

Representation rights. Beneficiaries may appoint a representative — including a family member, attorney, or advocate — to act on their behalf at any appeal level. Appointment is formalized through CMS Form CMS-1696. Attorneys representing Medicare beneficiaries in appeals are generally not subject to the same fee-schedule limitations that apply in Social Security proceedings, though fee arrangements in Medicare litigation vary by context. For a comparison of how representation rights intersect with broader elder law matters, see Durable Power of Attorney Legal Standards.

The Medicare appeals process does not operate in isolation from Medicaid Planning Legal Basics, particularly in dual-eligible situations where both programs may cover portions of a service and a denial by one program triggers separate remedies under the other.

References

• [Centers for Medicare & Medicaid Services (CMS) — Medicare Appeals](